Rupali Mukherjee

India tops global demand for data analytics jobs

Sep 24, 2024India is establishing itself as a major hub for data analytics, with nearly a quarter of its job postings focused on this skill set. The demand for AI roles has risen sharply, especially in India and Germany. Following the launch of ChatGPT-4, there was a notable increase in Generative AI-related job postings.

'Some brands can outperform the sector even in slowdown'

Sep 20, 2024Maximising shareholder value involves enhancing a brand's relevance and differentiation. This becomes crucial during economic slowdowns, particularly in the sluggish FMCG sector. Brands such as Maggie, Tanishq, Zomato, Royal Enfield, and Surf Excel excel by being meaningfully different and strategically positioned. These brands are resilient and drive growth as per Kantar BrandZ report.

US bankruptcy may not hit Tupperware India

Sep 19, 2024Tupperware's Indian operations remain stable despite the US-based parent company's Chapter 11 bankruptcy filing. Local manufacturing supports this stability, and recent festive season sales have surged. The company aims to evolve into a digital-first, technology-led enterprise while continuing to provide innovative products through consultants, retail partners, and online platforms.

Pfizer sets up global capability centre in India

Sep 18, 2024Pfizer Inc has inaugurated its first commercial analytics centre in Mumbai, India. This global capability centre will serve Pfizer's international markets outside the US, employing data analytics and AI to improve patient outcomes. The initiative is part of Pfizer’s strategy to modernize marketing and boost sales effectiveness across 140 international markets.

Public health groups raise concern on patent grant to promising, new HIV drug

Sep 17, 2024Patient and public health groups worry about a potential patent grant to Gilead Sciences for the HIV drug lenacapavir in India, which could hinder affordable generic production. The Indian Patent Office is set to review a pre-grant application by Sankalp Rehabilitation Trust on September 19, arguing the drug lacks novelty under India's Patent Act.

Panacea, Sanofi settle patent dispute over vaccine

Sep 17, 2024Panacea Biotec has resolved a patent infringement lawsuit with Sanofi Healthcare concerning its EasySix hexavalent vaccine. Under the settlement, Sanofi will refrain from launching its Shan6 vaccine in India and will withdraw opposition to Panacea's patent amendment application. The Delhi High Court concluded the case on September 13.

Freight rates flare up by nearly 70% in August

Sep 17, 2024Freight rates at Indian ports have increased by nearly 70% year-on-year in August due to global shipping disruptions and sustained demand. This rise, following a two-year hiatus, is anticipated to raise costs for Indian companies with international exposure. Contributing factors include geopolitical tensions and container shortages.

Sanofi Consumer makes its debut on stock exchanges

Sep 13, 2024Sanofi Consumer Healthcare has been listed on the BSE and NSE after its demerger from Sanofi India. Approved by the National Company Law Tribunal, this move aligns with Sanofi's global strategy. The company will now focus independently on consumer healthcare with brands like Allegra, DePURA, Avil, and Combiflam.

TV advertising in news genre up in first half, driven by F&B

Sep 12, 2024Television advertising in the news genre increased by 5% year-on-year during January-June, driven primarily by food and beverages. Cement emerged as the top category with Ultratech Cement leading. Hindi News led ad volumes, while Reckitt Benckiser and Hindustan Unilever retained their positions as top advertisers.

Nod to eye drop that can spell end to reading glasses

Sep 5, 2024